Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Albinterferon> ?p ?o }
Showing triples 1 to 54 of
54
with 100 triples per page.
- Albinterferon abstract "Albinterferon (alb-IFN, trade name Albuferon) is a recombinant fusion protein drug consisting of interferon alpha (IFN-α) linked to human albumin. Conjugation to human albumin prolongs the half-life of the IFN-α to about 6 days, allowing to dose it every two to four weeks.The drug was under investigation as an alternative to pegylated IFN-α-2a for the treatment of hepatitis C. In response to an FDA ruling, Novartis and Human Genome Sciences announced on October 5, 2010 that they will cease development of the drug.A French expert in hepatitis treatment, Dr. Yves Benhamou, member of the steering committee for a clinical trial of the drug was detained on criminal fraud charges by the F.B.I. agents on 11-01-2010 as he attended a conference in Boston because he allegedly tipped off a hedge fund manager about setbacks in the clinical trials (two participants in the trial had developed lung disease and one of them died); he had a consulting relationship with a manager of the hedge fund. The manager sold his entire stake in Human Genome Sciences before it announced the setbacks in Jan. 2008 and avoided $30 million in losses.".
- Albinterferon atcPrefix "L03".
- Albinterferon atcSuffix "AB12".
- Albinterferon atcSupplemental "(albinterferon alfa-2b)".
- Albinterferon casNumber "472960-22-8".
- Albinterferon wikiPageID "18979549".
- Albinterferon wikiPageLength "3624".
- Albinterferon wikiPageOutDegree "11".
- Albinterferon wikiPageRevisionID "707381595".
- Albinterferon wikiPageWikiLink Albumin.
- Albinterferon wikiPageWikiLink Category:Cytokines.
- Albinterferon wikiPageWikiLink Category:Hepatitis_C.
- Albinterferon wikiPageWikiLink Drug.
- Albinterferon wikiPageWikiLink Fusion_protein.
- Albinterferon wikiPageWikiLink Hepatitis_C.
- Albinterferon wikiPageWikiLink Human_Genome_Sciences.
- Albinterferon wikiPageWikiLink Interferon_type_I.
- Albinterferon wikiPageWikiLink Novartis.
- Albinterferon wikiPageWikiLink PEGylation.
- Albinterferon wikiPageWikiLink Peginterferon_alfa-2a.
- Albinterferon wikiPageWikiLinkText "Albinterferon".
- Albinterferon wikiPageWikiLinkText "albinterferon".
- Albinterferon atcPrefix "L03".
- Albinterferon atcSuffix "AB12".
- Albinterferon c "3796".
- Albinterferon casNumber "472960".
- Albinterferon chemspiderid "none".
- Albinterferon h "5937".
- Albinterferon molecularWeight "85.7".
- Albinterferon n "1015".
- Albinterferon o "1143".
- Albinterferon s "50".
- Albinterferon wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Albinterferon wikiPageUsesTemplate Template:Drugbox.
- Albinterferon wikiPageUsesTemplate Template:Immunostimulants.
- Albinterferon wikiPageUsesTemplate Template:Interferons.
- Albinterferon wikiPageUsesTemplate Template:Reflist.
- Albinterferon subject Category:Cytokines.
- Albinterferon subject Category:Hepatitis_C.
- Albinterferon hypernym Drug.
- Albinterferon type ChemicalSubstance.
- Albinterferon type Drug.
- Albinterferon type Chemical.
- Albinterferon type Redirect.
- Albinterferon type ChemicalObject.
- Albinterferon type Thing.
- Albinterferon type Q8386.
- Albinterferon comment "Albinterferon (alb-IFN, trade name Albuferon) is a recombinant fusion protein drug consisting of interferon alpha (IFN-α) linked to human albumin. Conjugation to human albumin prolongs the half-life of the IFN-α to about 6 days, allowing to dose it every two to four weeks.The drug was under investigation as an alternative to pegylated IFN-α-2a for the treatment of hepatitis C.".
- Albinterferon label "Albinterferon".
- Albinterferon sameAs Q4712444.
- Albinterferon sameAs m.04jjbcb.
- Albinterferon sameAs Q4712444.
- Albinterferon wasDerivedFrom Albinterferon?oldid=707381595.
- Albinterferon isPrimaryTopicOf Albinterferon.